Some have indicated that Johnson & Johnson will use Auris as a means to begin creating new ways to uncover and treat cancer, especially lung cancer.
This acquisition by Johnson & Johnson is a landmark deal, and it is one of the ten largest venture-capital deals in recent memory. Overall, Johnson & Johnson made significant waves in the medical community, and experts are excited to see how this acquisition plays out over 2019.
